Alaunos Therapeutics, Inc. Common Stock

TCRTNASDAQ • USD
1.60 USD
↘ 0.03 (1.84%)🟢LIVE (AS OF 01:56 PM EST)
🟢Market: OPEN

Shares of Alaunos Therapeutics, Inc. Common Stock (TCRT) are trading at $1.60. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$1.59
High?$1.69
Low?$1.49
Prev. Close?$1.63
Volume?52.7K
Avg. Volume?14.4M
VWAP?$1.60
Rel. Volume?0.00x
Bid / Ask
Bid?$1.40 × 100
Ask?$1.85 × 100
Spread?$0.45
Midpoint?$1.63
Valuation & Ratios
Market Cap?4.1M
Shares Out?3.3M
Float?2.7M
Float %?78.3%
P/E Ratio?N/A
P/B Ratio?6.35
EPS?-$1.68
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
Employees
1
Market Cap
4.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2005-08-24
Address
501 E LAS OLAS BLVD
FORT LAUDERDALE, FL 33301
Phone: (346) 355-4099
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
71
Piotroski F-Score?0/9Weak
Altman Z-Score?-861.79Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.85%Elevated
Short Interest?184.4K
Days to Cover?1.0
Free Float2.7M
Avg Daily Volume7.6M
Settlement Date2026-10-30
Financial Health
Current Ratio?0.77Weak
Quick Ratio?0.77Weak
Cash Ratio?0.14Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
29
6.35FAIR▾
P/S?
Peers
100
S&P
3
1,380.33HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.0CHEAP▾
EV/Sales?
Peers
100
S&P
3
1,338.99HIGH▾
Returns & Efficiency
ROE?
S&P
3
-654.1%WEAK▾
ROA?
S&P
3
-281.3%WEAK▾
Cash Flow & Enterprise
FCF?$-2825000
Enterprise Value?$4.0M
Fundamentals ratios updated end of day